4.5 Article

Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Acute and Persistent Symptoms in Children With Polymerase Chain Reaction (PCR)-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Compared With Test-Negative Children in England: Active, Prospective, National Surveillance

Maria Zavala et al.

Summary: This study investigates the ongoing symptoms in children with COVID-19 and compares them with a symptomatic control group. The findings suggest that children with symptomatic COVID-19 have a slightly higher prevalence of ongoing symptoms compared to symptomatic controls. However, mental health symptoms were high and equally prevalent in both groups.

CLINICAL INFECTIOUS DISEASES (2022)

Article Pediatrics

Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study

Luise Borch et al.

Summary: The study aimed to evaluate symptoms and duration of 'long COVID' in children. It found that most children recovered from symptoms within 1-5 months, suggesting that long COVID in children is rare and mainly of short duration.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Article Pediatrics

COVID-19 in children: clinical and epidemiological spectrum in the community

Cesar Garcia-Vera et al.

Summary: This study in Spain's Aragon region on pediatric COVID-19 cases aged 0 to 14 years showed that half of the cases were asymptomatic, with transmission mainly occurring within family environments. Symptomatic cases exhibited mild symptoms, with complications being very rare.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Letter Medicine, General & Internal

Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents

Ben Y. Reis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Multidisciplinary Sciences

The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide

Taito Kitano et al.

Summary: This study found significant differences in pediatric COVID-19 mortality and intensive care unit admission rates between low- and middle-income countries and high-income countries, suggesting a potentially larger impact of pediatric COVID-19 fatality in LMICs.

PLOS ONE (2021)

Editorial Material Infectious Diseases

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs

Eskild Petersen et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Pediatrics

Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

Erika Molteni et al.

Summary: Most school-aged children in the UK with SARS-CoV-2 infection are asymptomatic or experience mild illness, with longer duration and higher symptom burden observed in older children. Persistence of illness is more common in older children, but symptom burden does not increase over time and most recover within 56 days. Children who test negative for SARS-CoV-2 may also experience prolonged illness with higher symptom burden.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Article Pediatrics

Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis

Ulla Koskela et al.

Summary: The study found a decrease in Kawasaki disease cases and a low occurrence rate of MIS-C during the COVID-19 pandemic. The reduced incidence of respiratory infections and the protective effect of social distancing suggest a potential link between transmissible microbes and Kawasaki disease.

ACTA PAEDIATRICA (2021)

Article Public, Environmental & Occupational Health

Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study

Laura Espenhain et al.

Summary: Seroprevalence studies conducted in Denmark in 2020 have shown an increase in seroprevalence estimates throughout the year, especially in the 12-29 age group and metropolitan areas. Hospitalization rates were significantly higher in older age groups, and although many seropositive individuals were asymptomatic, loss of taste/smell was a specific symptom.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Letter Medicine, General & Internal

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents

Thomas Radtke et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

Kashif Ali et al.

Summary: The study demonstrates that the mRNA-1273 vaccine has good safety profile in adolescents aged 12 to 17 years, with immune response similar to that in young adults. It also proves the efficacy of the vaccine in preventing Covid-19 in this age group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck et al.

Summary: The BNT162b2 vaccine showed favorable safety profile and a greater immune response in 12-to-15-year-old recipients compared to young adults, and demonstrated high effectiveness against Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

Hannah Chung et al.

Summary: The study demonstrates that two doses of mRNA covid-19 vaccines are highly effective against symptomatic infection and severe outcomes. However, the effectiveness of one dose is lower, particularly for older adults shortly after the first dose. For adults aged >=70 years, vaccine effectiveness estimates were observed to be lower for intervals shortly after one dose but were comparable to those for younger people for all intervals after 28 days.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Pediatrics

Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England

Defne Saatci et al.

Summary: This study investigated the association between race and childhood COVID-19 testing and hospital outcomes. It found that there were some race-specific disparities in severe COVID-19 outcomes among children in England.

JAMA PEDIATRICS (2021)

Article Pediatrics

Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study

Stephen T. J. Ray et al.

Summary: This UK study on children with SARS-CoV-2 infection and neurological or psychiatric complications identified key differences between those with primary neurological disorders and those with PIMS-TS, highlighting the need for further investigation into underlying mechanisms and longer-term outcomes.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Article Medicine, General & Internal

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Amanda B. Payne et al.

Summary: In this study, it was found that Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare complication associated with SARS-CoV-2 infection, with higher incidence rates among Black, Hispanic or Latino, and Asian or Pacific Islander individuals. Further research is needed to explore the variations by race/ethnicity and age group.

JAMA NETWORK OPEN (2021)

Article Infectious Diseases

COVID-19 in a Subset of Hospitalized Children in Israel

Shalom Ben-Shimol et al.

Summary: A nationwide surveillance in Israel revealed that most pediatric COVID-19 cases, including hospitalized cases, were mild, with only one third presenting with respiratory symptoms. Pediatric Inflammatory Multisystem Syndrome (PIMS), although rare, requires a high index of suspicion and has a favorable prognosis with appropriate treatment.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

Article Virology

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

Puck B. van Kasteren et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Pediatrics

Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration

Kanecia O. Zimmerman et al.

JAMA PEDIATRICS (2019)

Editorial Material Public, Environmental & Occupational Health

Data Resource Profile: The Danish National Prescription Registry

Anton Pottegard et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)

Article Infectious Diseases

The Danish vaccination register

T Grove Krause et al.

Eurosurveillance (2017)

Article Multidisciplinary Sciences

Data, disease and diplomacy: GISAID's innovative contribution to global health

Stefan Elbe et al.

GLOBAL CHALLENGES (2017)

Review Public, Environmental & Occupational Health

The Danish National Patient Registry: a review of content, data quality, and research potential

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2015)

Article Infectious Diseases

The Danish Microbiology Database (MiBa) 2010 to 2013

M. Voldstedlund et al.

EUROSURVEILLANCE (2014)

Article Public, Environmental & Occupational Health

The Danish National Health Service Register

John Sahl Andersen et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)